NeuBase Therapeutics Cash from Financing (TTM) Analysis

NeuBase Therapeutics Inc (NBSE)

0.4121 0.00 (0.00%) USD | NASDAQ | May 02, 16:00

0.4121 0.00 (0.00%) After-Hours: 16:51

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
September 30, 2023	4.254M
June 30, 2023	4.402M
March 31, 2023	-0.172M
December 31, 2022	-0.1107M
September 30, 2022	-0.257M
June 30, 2022	-0.385M
March 31, 2022	42.16M
December 31, 2021	42.19M
September 30, 2021	42.34M
June 30, 2021	42.48M
March 31, 2021	33.20M
December 31, 2020	33.15M
September 30, 2020	33.11M
June 30, 2020	46.78M
March 31, 2020	13.55M
December 31, 2019	13.59M
September 30, 2019	13.60M
June 30, 2019	-0.1815M
March 31, 2019	-0.2879M
December 31, 2018	-0.2781M
September 30, 2018	-0.0863M
June 30, 2018	0.0135M
March 31, 2018	12.71M
December 31, 2017	12.70M
September 30, 2017	19.46M

Date	Value
June 30, 2017	19.42M
March 31, 2017	6.762M
December 31, 2016	6.762M
September 30, 2016	-0.15M
June 30, 2016	-0.1781M
March 31, 2016	-0.1757M
December 31, 2015	26.46M
September 30, 2015	26.45M
June 30, 2015	26.46M
March 31, 2015	43.38M
December 31, 2014	16.75M
September 30, 2014	16.97M
June 30, 2014	17.04M
March 31, 2014	5.197M
December 31, 2013	5.269M
September 30, 2013	5.180M
June 30, 2013	6.888M
March 31, 2013	2.972M
December 31, 2012	2.997M
September 30, 2012	3.950M
June 30, 2012	2.243M
March 31, 2012	1.147M
December 31, 2011	1.498M
September 30, 2011	0.9814M
June 30, 2011	0.9846M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.385M

Minimum

Jun 2022

46.78M

Maximum

Jun 2020

20.21M

Average

13.60M

Median

Cash from Financing (TTM) Benchmarks